Entity
Company
Location
C/O Oaktree Capital Management, L.P., 333 S. Grand Avenue, 28 Th Floor, Los Angeles, CA
Signature
Oaktree GCP Fund Delaware Holdings, L.P., By: Oaktree Global Credit Plus Fund GP, L.P., Its: GP, By: Oaktree Global Credit Plus Fund GP Ltd., Its: GP, By: Oaktree Capital Management, L.P., Its: Director, /s/ Henry Orren, Senior Vice President
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Oaktree GCP Fund Delaware Holdings, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
IMPEL PHARMACEUTICALS INC 10%+ Owner Warrants 3.12M Nov 30, 2023 Indirect

Insider Reports Filed by Oaktree GCP Fund Delaware Holdings, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IMPL IMPEL PHARMACEUTICALS INC Nov 30, 2023 1 $0 4 Dec 4, 2023 10%+ Owner
IMPL IMPEL PHARMACEUTICALS INC Nov 10, 2023 0 $0 3 Nov 20, 2023 10%+ Owner